GIST in Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation

Cancer Clinical Trial

Official title:

Giving Information Strategically and Transparently in Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03959046
• Other study ID #: 1807019470
• Secondary ID: 5R35CA197730
• Status: Withdrawn
• Phase: N/A
• Start date: June 2021
• Est. completion date: June 2021

Study information

• Verified date: June 2021
• Source: Weill Medical College of Cornell University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess the efficacy of using GIST language when speaking to patients about bone marrow and hematopoietic stem cell transplantation.

Description:

Hematopoietic stem cell/bone marrow transplantation (HSCT/BMT) is a high-risk, complicated procedure that is poorly understood by patients, posing a challenge for informed decision-making. One study found that 69.7% of patients needed more information about HSCT to make an informed decision. Furthermore, for most patients who seek HSCT/BMT as treatment, transplantation is the only viable option for long-term, disease-free survival. In light of limited options, it is often assumed that patients will choose to undergo transplantation by default, which might undermine efforts to ensure that patients are fully informed. Given the context in which the decision to undergo transplantation are made, there is a clear and present need to ensure that patients are properly informed about HSCT/BMT.

Unfortunately, this need does not seem to be adequately met. For example, studies have shown that patients tend not to remember rates of risks and complications. One study found that after completing HSCT, patients recalled a mortality risk rate lower than those provided by physicians at their initial consultation (20% vs. 30%, respectively). Findings such as this highlight the need to improve the informed consent process for patients confronting the decision to undergo HSCT/BMT.

The present study aims to improve the informed consent process by proposing a new approach to patient-physician communication, called Giving Information Simply and Transparently (GIST), that will train physicians to speak more understandably, with the goal of improving patients understanding of the procedures they intend to pursue. This approach is based upon Dr. Valerie Reyna's Fuzzy Trace Theory which posits that patients focus on the bottom-line gist of information when formulating their treatment preferences. Patient understanding will be tested via assessments administered after their consultation visit, 30 days after initiation of chemotherapy, and 100 days after initiation of chemotherapy.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: June 2021
• Est. primary completion date: June 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 99 Years

Eligibility

Inclusion Criteria:

• acute myeloid leukemia with high or intermediate risk in first complete remission acute myeloid leukemia OR myelodysplastic syndrome beyond first remission chronic myeloid leukemia with accelerated phase or blast crisis acute lymphocytic leukemia Myeloma lymphoma with a sensitive relapse lymphoma with a resistant relapse first time undergoing consultation at this institution's HSCT/BMT program Fluent in English

Exclusion Criteria:

• Cognitively impaired

• Not fluent in English

Related Conditions & MeSH terms

• Cancer
• Liquid Tumor
• Psychological Feedback

Intervention

Behavioral:
• GIST
The GIST intervention will train physicians in an alternative way of communicating with their patients.

Locations

Country	Name	City	State
United States	Weill Cornell Medical Center	New York	New York

Sponsors (3)

Lead Sponsor	Collaborator
Weill Medical College of Cornell University	National Cancer Institute (NCI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	The Human Connection (THC) Scale	The effect on changing physician communication on patient-physician relationships will be measured by The Human Connection (THC) scale. THC is a validated 16 item questionnaire that measures the extent to which patients felt a sense of mutual understanding, caring, and trust with their physicians. Patients are asked to circle one of four phrases that answers the questions. The 16-item THC questionnaire was internally consistent (Cronbach's a =.90) and valid, based on its expected positive association with emotional acceptance of the terminal illness (r=.31, P<.0001). Scores range from 16 (the lowest score, indicating a weak therapeutic alliance) and 64 (the high score, indicating a strong therapeutic alliance).	One week, one month and three months from baseline (T2, T3, and T4)
Other	Levels of anxiety and depression in patients	levels of anxiety and depression will be assessed via the Hospital Anxiety and Depression Scale (HADS). It is a verified and brief 14-item tool that asks patients to choose a 1 out of 4 possible responses to each statement, with each response being assigned to a score of 0, 1, 2, or 3. 7 statements correspond to measuring depression, while the other 7 corresponding to measuring anxiety. Score of 0-7 indicates that the patient is "normal; 8-10 indicates the patient is borderline; and 11-21 indicates abnormal.	1 week, 1 month and 3 months from baseline (T2, T3, and T4)
Other	Health Literacy in older adults compared to younger adults	The researchers have developed a brief assessment of patient knowledge of: a) why the participants are a candidate for HSCT/BMT; b) what the procedure involves; c) risks and benefits posed by HSCT/BMT. The assessment will consist of multiple choice questions, with one fill-in-the-diagram question. The high score is 90, and the low score is 18. A score of 90 means that the participant fully understands the three points listed above. A score of 18 means that the participant has little to no understanding of the three points listed above. We will compare the scores of older adults (>65) to younger adults (<65) to see which group overall has a higher score.	Baseline, 1 week, 1 month and 3 months from baseline (T1, T2, T3, and T4)
Other	Assessment of patient's health literacy	Assessment of patient's health literacy via Rapid Estimate of Adult Literacy in Medicine - Short Form(REALM-SF) will be administered to control for variable health literacy. REALM-SF is a validated and brief literacy assessment tool of a patient's health literacy. REALM-SF consists of a list of 7 medically related words that is shown to the patient. Patients are asked to read the words out loud in order of the list, with the option of saying "pass" when they encounter a word that they do not recognize, allowing them to move onto the next word; alternatively, patients taking longer than 5 seconds to read a word will be told to move onto the next word by the interviewer. Each word a patient recognizes is a point that is used to score the assessment. 0 points is equivalent to a 3rd grade reading level, 1-3 points is equivalent to a 4th to 6th grade level, 4-6 points is equivalent to a 7th to 8th grade level, and 7 points is equivalent to at least a high school level.	1 week, 1 month and 3 months from baseline (T2, T3, and T4)
Primary	Change from 1 week post baseline understanding at 3 months	Evidence that patients assigned to physicians trained in the GIST approach will have improved recall of information and be able to answer more questions correctly about HSCT/BMT than those assigned to care as usual. The researchers have developed a brief assessment of patient knowledge of: a) why the participants are a candidate for HSCT/BMT; b) what the procedure involves; c) risks and benefits posed by HSCT/BMT. The assessment will consist of multiple choice questions, with one fill-in-the-diagram question. The high score is 90, and the low score is 18. A score of 90 means that the participant fully understands the three points listed above. A score of 18 means that the participant has little to no understanding of the three points listed above.	1 week, 1 month and 3 months from baseline (T2, T3, and T4)
Secondary	Patient's emotional acceptance of their illness	We will use 5 relevant items from the validated PEACE scale which asks patients about how accepting they are of their illness. Responses include "not at all", "to a slight extent", "to some extent", "to a large extent". The questionnaire is composed of two combined subscales: a 2-item "Peaceful Acceptance" and a 3-item "Struggle with Illness" subscale. Both subscales are associated with patients' self-reported peacefulness "Struggle with Illness" scores are associated with acknowledgement of cognitive terminal illness. The low score for this scale is 5 (indicating little acceptance) and the high score is 20 (indicating high acceptance).	1 week, 1 month and 3 months from baseline (T2, T3, and T4)
Secondary	Patient's emotional acceptance of their lives	The MEPSI is an 8 item questionnaire (shortened from the original) that asks patients to respond to phrases regarding how they view their lives. Responses include "not at all", "to a slight extent", "to some extent", "to a large extent". The questionnaire is composed of two combined subscales: a 4 item "Positive" subscale and a 4-item "Negative" subscale. The low score for this scale is 8 (indicating little acceptance) and the high score is 32 (indicating high acceptance).	1 week, 1 month and 3 months from baseline (T2, T3, and T4)